Biotech companies at BioTechX Europe 2026

Oct 6–8, 2026 Basel, Switzerland ~3k attendees Website

25 biotech companies are at BioTechX Europe 2026 — 19 presentations on the program and 9 with a booth in the exhibit hall. Most represented: Etcembly (1 on the program), Oncodesign Precision Medicine (1 on the program), Syngenta (1 on the program). 12 of them have their own page in this guide. As of Sep 26, 2026.

All 268 organizations at BioTechX Europe 2026 →

Showing 1–19 of 25 organizations

Organization	BioTechX Europe 2026 Attendance
E Etcembly
Biotech Biotech using machine learning to discover and engineer T-cell receptor immunotherapies.	Chair Thu Oct 8 11:05 Chair's remarks Large Language models Talk Thu Oct 8 11:10 Discovery and engineering of next-gen immunotherapies with EMLy Co-pilot Large Language models
OP Oncodesign Precision Medicine
Biotech French biotech developing kinase inhibitors from its Nanocyclix macrocycle platform, using data-driven AI and machine learning.	Chair Tue Oct 6 15:25 Chair's remarks AI in Drug Discovery and Development Talk Thu Oct 8 11:30 The (R)evolution of Nanocyclix: A Data-Driven AI/ML Platform for Novel Kinase Inhibitors AI in Drug Discovery and Development
S Syngenta
Biotech Agricultural science company developing crop protection products and seeds.	Panel Tue Oct 6 17:25 Data Management & Readiness for AI Data Management, Storage and Architecture · with Roche, UCB, AstraZeneca Chair Thu Oct 8 09:00 Chair's remarks Keynotes
ALLOX Barcelona, Spain
allox.bio BiotechStart-up Combines systematic mutagenesis, high-throughput phenotyping and biophysical modelling to map protein function and develop better drugs.	Booth Exhibiting at Booth S19 Talk Thu Oct 8 12:10 Mapping therapeutic hotspots at scale to develop better drugs Startup Pitches Bioinformatics & cheminformatics
M Mycolever
BiotechStart-up Discovers and develops fungal biocompounds for eco-friendly, high-performance formulations, starting with skin health.	Booth Exhibiting at Booth S8 Talk Thu Oct 8 12:30 From Nature to Industry: Unlocking the potential of Fungal biocompounds for skin health and beyond Startup Pitches
Owkin
owkin.com BiotechSilver sponsor Agentic AI company combining biological large language models with multimodal patient data, including spatial omics, for drug research.	Booth Exhibiting at Booth 178 Talk Wed Oct 7 12:05 Building an AI Scientist for a new generation of Pharma R&D How an AI research assistant built on varied patient data helps drug researchers turn scientific questions into testable hypotheses faster.
AT Agomab Therapeutics Ghent, Belgium
Biotech Develops organ-restricted small molecules for fibrotic diseases.	Talk Tue Oct 6 11:45 AI in Biotech: From Ambition to Value AI in Drug Discovery and Development
A AIGENDRUG
	Talk Thu Oct 8 11:50 Generating drug candidates in the chemist-in-the-loop framework Bioinformatics + InSilico R&D
B BioCopy
	Talk Wed Oct 7 12:25 From Prediction to Validation: An Industry-Standard Approach to TCR-Mimic Antibody Development AI in Drug Discovery and Development
BP Brenus Pharma
Biotech Develops cancer immunotherapies based on stimulated tumor cells.	Talk Tue Oct 6 11:45 Using ML-enabled multi-omics bioinformatics to accelerate immunotherapy development Bioinformatics + InSilico R&D
dsm-firmenich
dsm-firmenich.com Biotech Nutrition, health and beauty ingredients company formed by the merger of DSM and Firmenich.	Talk Thu Oct 8 11:10 Keeping AI Safe: Data Hygiene, Supply Chain Defense, and Leakage Prevention AI in Drug Discovery and Development
Idorsia Allschwil, Switzerland
idorsia.com Biotech Swiss biopharmaceutical company discovering, developing and commercializing small-molecule medicines.	Talk Tue Oct 6 11:45 From Data to Design: Building Platforms for Medicinal Chemistry Cheminformatics
IL Ignota Labs
Biotech AI-driven drug company that uses safety prediction to rescue drug candidates that failed on toxicity.	Keynote Thu Oct 8 13:20 Women in Leadership Keynote Panel Keynotes · with Bayer, Pistoia Alliance, Our Future Health +1 more
Moderna Cambridge, MA
modernatx.com Biotech Biotech developing and marketing mRNA medicines and vaccines.	Talk Wed Oct 7 15:50 Designing Agent-Ready Regulatory and Pharmacovigilance Processes: Data Foundations, Compliance, and Applied Use Cases Clinical Technology & Innovation
Molecular Partners Schlieren, Switzerland
molecularpartners.com Biotech Clinical-stage biotech developing DARPin protein therapeutics.	Panel Tue Oct 6 17:25 From Data to Diagnosis: The Power of Multi-Omics in Clinical Research Bioinformatics + InSilico R&D · with University of Alabama at Birmingham, CSEM, University of Vienna
QP Qubit Pharmaceuticals Paris, France
Biotech French drug discovery company combining quantum physics, molecular simulation and AI to design new medicines.	Talk Thu Oct 8 11:10 Quantum and AI to discover new medicines Quantum Pharma
AT Adoram Therapeutics
Biotech Swiss university spin-off developing therapies for cancer and inflammation.
argenx	—
Transgene Illkirch-Graffenstaden, France
transgene.fr Biotech French biotech developing viral vector-based immunotherapies for cancer.